Liensinine also suppresses IL-1β-induced chondrocyte inflammation via NF-κB inhibition and improves cartilage damage in osteoarthritis models [64], indicating its potential utility in osteoarthritis treatment. This evidence concerns the gene NFKB1 and osteoarthritis.